Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Pierre Fabre pursues its commitment against rare diseases in the pediatric, oncology and dermatology fields. 2023-02-06 18:00
Qurient Co. Ltd. and TB Alliance Announce Exclusive License Agreement for Telacebec (Q203), a New Anti-Tuberculosis Agent 2023-02-03 14:34
Innovation Deficit: Funds for Neglected Diseases like TB are Falling Short 2023-01-31 21:30
Delivery of 170,000 Bottles of Azvudine Tablets During Spring Festival to Help Rural Areas Weather the Epidemic 2023-01-31 16:10
Chula Medicine Reveals Detection of Latent Dementia 2023-01-30 11:01
Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster 2023-01-18 21:00
CGTN: China's COVID-19 vaccines proven safe, effective by trials and data 2023-01-17 23:50
CGTN: China protects lives, shares experience in global COVID-19 fight 2023-01-16 07:29
CGTN: TCM continues to play significant role in treating COVID-19 2023-01-11 23:09
CGTN: China downgrades COVID-19 rules as nation readies for normal life 2023-01-09 10:42
China welcomes first arrivals following downgraded COVID management 2023-01-09 07:40
CGTN: China's preparedness for adjusting its COVID-19 policies 2023-01-05 04:07
CGTN: China's dynamic zero-COVID policy sets the foundation for reopening 2023-01-05 04:05
China's optimization of control measures lays solid foundation for COVID-19 response 2023-01-04 15:39
Everest Medicines Announces New Strategic Plans, Reinforcing Transformation into a Fully Integrated Biopharmaceutical Company 2023-01-03 16:00
CGTN: China monitors coronavirus mutations to adjust COVID-19 response 2023-01-03 08:27
CGTN: Xi Jinping salutes ordinary people's extraordinary efforts in New Year Address 2023-01-03 07:52
CGTN:How do emergency wards in China cope with increasing COVID patients? 2023-01-03 06:54
Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates 2022-12-30 21:00
Grand Pharma Announces Successful Clinical Progress of its Oral 3CL Protease Inhibitor GS221 Against COVID-19 2022-12-30 13:23
1 4 5 6 7 8 71